NASDAQ:RANI

Rani Therapeutics Holdings Stock Insider Trading

Healthcare > Biotechnology

Buy RANI

*Your capital is at risk

$0.88

+0.0174 (+2.03%)

At Close: Jun 03, 2026

Rani Therapeutics Holdings Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -65.07. In total, the insiders bought 12.48M and sold 14.16M RANI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-65.07
● Buy	12.48M shares
● Sell	14.16M shares
80% Buy Activity Moderate Positive Correlation
Buy Signal Low Confidence May 28, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -65.07. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (80% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
May 28, 2026 Buy	Director Stock Option (Right to Buy) A-Award	Ausiello Dennis A Director	Director	123 600 Value: $117.6K
May 28, 2026 Buy	Director Stock Option (Right to Buy) A-Award	Bassan Abraham Director	Director	123 600 Value: $117.6K
May 28, 2026 Buy	Director Stock Option (Right to Buy) A-Award	Rometty Lisa Ann Director	Director	123 600 Value: $117.6K
May 28, 2026 Buy	Director Stock Option (Right to Buy) A-Award	Imran Mir A	Director	123 600 Value: $117.6K
May 28, 2026 Buy	Director Stock Option (Right to Buy) A-Award	Butel Jean Luc Director	Director	123 600 Value: $117.6K
May 28, 2026 Buy	Director Stock Option (Right to Buy) A-Award	Bailey Vasudev Jaiprakash Director	Director	123 600 Value: $117.6K
Mar 18, 2026 Buy	Stock Option (Right to Buy)	Javadi Alireza Chief Technical Officer	Officer	159 000 Value: $98.1K
Mar 18, 2026 Buy	Stock Option (Right to Buy)	Javadi Alireza Chief Technical Officer	Officer	40 750 Value: $146.7K
Mar 18, 2026 Buy	Stock Option (Right to Buy)	Javadi Alireza Chief Technical Officer	Officer	17 084 Value: $48.5K
Mar 18, 2026 Buy	Stock Option (Right to Buy)	Javadi Alireza Chief Technical Officer	Officer	3 416 Value: $18.6K
Mar 18, 2026 Buy	Stock Option (Right to Buy)	Javadi Alireza Chief Technical Officer	Officer	9 166 Value: $121.1K
Mar 18, 2026 Buy	Class A Common Stock	Javadi Alireza Chief Technical Officer	Officer	0 Value: $0
Oct 23, 2025 Buy	Common Stock J-Other	Bailey Vasudev Jaiprakash Insider	Other	0 Value: $0
Oct 23, 2025 Buy	Stock Option (Right to Buy) A-Award	Bailey Vasudev Jaiprakash Director	Director	100 000 Value: $209.0K
Oct 23, 2025 Buy	Warrant to Purchase Class A Common Stock P-Purchase	Imran Mir A	Director	2 083 334 Value: $1.00M
Oct 23, 2025 Buy	Class A Common Stock P-Purchase	Imran Mir A	Director	2 083 334 Value: $1.26M
Oct 23, 2025 Buy	Common Stock J-Other	Bassan Abraham Insider	Other	0 Value: $0
Oct 23, 2025 Buy	Stock Option (Right to Buy) A-Award	Bassan Abraham Director	Director	100 000 Value: $209.0K
Oct 21, 2025 Sell	Class A Common Stock S-Sale	South Cone Investments Limited Partnership 10 Percent Owner	10% Owner	4 000 000 Value: $11.1M
Oct 20, 2025 Sell	Class A Common Stock S-Sale	South Cone Investments Limited Partnership 10 Percent Owner	10% Owner	1 923 000 Value: $4.64M
Aug 01, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Mckinley Kate Chief Business Officer	Officer	120 000 Value: $63.4K
Aug 01, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Mckinley Kate Chief Business Officer	Officer	120 000 Value: $63.4K
May 28, 2025 Buy	Director Stock Option (Right to Buy) A-Award	Nanavaty Maulik Director	Director	50 000 Value: $31.0K
May 28, 2025 Buy	Director Stock Option (Right to Buy) A-Award	Imran Mir A Director	Director	50 000 Value: $31.0K
May 28, 2025 Buy	Director Stock Option (Right to Buy) A-Award	Rometty Lisa Ann Director	Director	50 000 Value: $31.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT RANI THERAPEUTICS HOLDINGS, INC.

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-al...

Read Full Profile Here